【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Five forces analysis
PART 06: Market segmentation by application
• Global regenerative medicine market
• Global next-generation antibodies market
• Global next-generation insulin products market
• Global next-generation recombinant coagulation factors market
PART 07: Geographical segmentation
• Next-generation biologics market in Americas
• Next-generation biologics market in EMEA
• Next-generation biologics market in APAC
PART 08: Market drivers
• Increase in demand for ADCs
• Advanced technological innovations
• Reimbursement support for next-generation biologics
• Special regulatory drug designations for biologics
PART 09: Impact of drivers
PART 10: Market challenges
• Complexities in manufacturing of biologics
• Complicated regulatory framework
• Difficulties in patient recruitment for conducting clinical trials, high cost, and failure rate in clinical trials
• Critical ethical challenges in clinical trial design
PART 11: Impact of drivers and challenges
PART 12: Market trends
• Focus on regenerative medicines
• Focus on oral insulin therapies
• Development of gene and cell therapy-based products
• Emergence of targeted and combination therapies
PART 13: Vendor landscape
• Competitive scenario
• Key news
• Other prominent vendors
PART 14: Key vendor analysis
• Biogen
• F. Hoffmann-La Roche
• Novo Nordisk
• Sanofi4
• Takeda Pharmaceuticals
PART 15: Appendix
• List of abbreviations
PART 16: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Global next-generation biologics market
Exhibit 03: Overview of next-generation biologics market 2016-2020
Exhibit 04: Key strategies in global next-generation biologics market
Exhibit 05: Global next-generation biologics market snapshot: Developed and emerging markets 2015
Exhibit 06: Global next-generation biologics market 2015-2020 ($ billions)
Exhibit 07: Opportunities faced by biologics industry today
Exhibit 08: Five forces analysis
Exhibit 09: Global next-generation biologics market segmentation by therapies
Exhibit 10: Market share of next-generation biologics by application
Exhibit 11: Market overview of global regenerative medicine market
Exhibit 12: Sub-segmentation in regenerative medicine market
Exhibit 13: Global regenerative medicine market 2015-2020 ($ billions)
Exhibit 14: Funds from federal agencies for regenerative medicine research in 2014 ($ millions)
Exhibit 15: Cell therapy overview
Exhibit 16: Gene therapy products available in Europe
Exhibit 17: R&D in tissue scaffold
Exhibit 18: Opportunity analysis of global regenerative medicine market
Exhibit 19: Market overview of next-generation antibodies
Exhibit 20: Sub-segmentation in next-generation antibodies market
Exhibit 21: Global next-generation antibodies market 2015-2020 ($ billions)
Exhibit 22: Global next-generation antibodies market: Present and future scenario
Exhibit 23: Opportunity analysis of global next-generation antibodies market
Exhibit 24: Market overview of next-generation insulin products
Exhibit 25: Factors affecting global next-generation insulin products market
Exhibit 26: Global next-generation insulin products market 2015-2020 ($ millions)
Exhibit 27: Opportunity analysis of global next-generation insulin products market
Exhibit 28: Market overview of next-generation recombinant coagulation factors
Exhibit 29: Global next-generation recombinant coagulation factors market 2015-2020 ($ billions)
Exhibit 30: Opportunity analysis of global next-generation recombinant coagulation factors market
Exhibit 31: Impact of factors affecting the market 2015 and 2020
Exhibit 32: Global next-generation biologics market: Segmentation by geography (2015-2020)
Exhibit 33: Global next-generation biologics market segmentation by region: Market growth lifecycle analysis 2015
Exhibit 34: Overview of next-generation biologics market in Americas
Exhibit 35: Next-generation biologics market in Americas 2015-2020 ($ billions)
Exhibit 36: Stem cell research policies in Americas
Exhibit 37: Overview of next-generation biologics market in EMEA
Exhibit 38: Distribution of major cell therapy vendors in Europe 2011
Exhibit 39: Next-generation biologics market in EMEA 2015-2020 ($ billions)
Exhibit 40: Stem cell research policies in EMEA
Exhibit 41: Overview of next-generation biologics market in APAC
Exhibit 42: Global next-generation biologics market revenue by geography 2015-2020 ($ billions)
Exhibit 43: Key regenerative medicine market developments in Japan by global vendors 2015
Exhibit 44: Next-generation biologics market in APAC 2015-2020 ($ billions)
Exhibit 45: Stem cell research policies in APAC
Exhibit 46: ADC molecules currently under clinical trials
Exhibit 47: Advances in ADCs technology
Exhibit 48: Technologies used in next-generation biologics
Exhibit 49: Breakdown of CIRM funding in various stem cell research funding in 2014 ($ billions)
Exhibit 50: Active programs under CIRM in 2014
Exhibit 51: EC funding
Exhibit 52: Some of special regulatory designations approved by US FDA
Exhibit 53: Special regulatory designation approved by EU
Exhibit 54: Impact of drivers
Exhibit 55: Ethical issues that are faced by various institutes at different phases of cell therapy research
Exhibit 56: Impact of drivers and challenges
Exhibit 57: Impact of trends on global next-generation biologics market
Exhibit 58: Some of the regenerative medicines under development for the treatment of various musculoskeletal disorders
Exhibit 59: Planned clinical trials of iPS cell-based therapies
Exhibit 60: Regenerative medicines for IBS under development
Exhibit 61: Some of the mid- and late-stage pipeline products for regenerative medicine
Exhibit 62: Oral insulin pipeline portfolio
Exhibit 63: Gene therapies under development for hemophilia
Exhibit 64: Geographical presence of key vendors
Exhibit 65: Competitive scenario of global next-generation biologics market vendors 2015-2020
Exhibit 66: Biogen: Key highlights
Exhibit 67: Biogen: Strength assessment
Exhibit 68: Biogen: Strategy assessment
Exhibit 69: Biogen: Opportunity assessment
Exhibit 70: F. Hoffmann-La Roche: KADCYLA pipeline products
Exhibit 71: F. Hoffmann-La Roche: Key highlights
Exhibit 72: F. Hoffmann-La Roche: Strength assessment
Exhibit 73: F. Hoffmann-La Roche: Strategy assessment
Exhibit 74: F. Hoffmann-La Roche: Opportunity assessment
Exhibit 75: Novo Nordisk: Highlights
Exhibit 76: Novo Nordisk: Strength assessment
Exhibit 77: Novo Nordisk: Strategy assessment
Exhibit 78: Novo Nordisk: Opportunity assessment
Exhibit 79: Sanofi: Highlights
Exhibit 80: Sanofi: Strength assessment
Exhibit 81: Sanofi: Strategy assessment
Exhibit 82: Sanofi: Opportunity assessment
Exhibit 83: Takeda Pharmaceuticals: Highlights
Exhibit 84: Takeda Pharmaceuticals: Strength assessment
Exhibit 85: Takeda Pharmaceuticals: Strategy assessment
Exhibit 86: Takeda Pharmaceuticals: Opportunity assessment
【レポート販売概要】
■ タイトル：次世代生物学的製剤の世界市場2016-2020：再生医療、次世代抗体、次世代インスリン製品、次世代組み換え凝固因子■ 英文：Global Next-Generation Biologics Market 2016-2020
■ 発行日：2016年11月25日
■ 調査会社：Technavio
■ 商品コード：IRTNTR10904
■ 調査対象地域：グローバル
- 世界の農業用ロボット市場：提供別、種類別（UAV、搾乳ロボット、ドライバーレストラクター、自動収穫システム）、農業環境別、農産物別、用途別（収穫管理、フィールドファーミング）、地域別“The agricultural robots market is projected to grow at a CAGR of 22.8% during 2019–2024” The agricultural robots market is expected to grow from USD 7.4 billion in 2020 and is projected to reach USD 20.6 billion by 2025; it is expected to grow at a CAGR of 22.8% during the forecast period. A shortage of new farmers, as indicated by the rising average age of farmers is driving the further use of a …
- メキシコの麻酔装置・呼吸装置市場Mexico Anesthesia and Respiratory Devices Market Outlook to 2021 - Airway and Anesthesia Devices, Anesthesia Machines, Pain Management Devices, Regional Anesthesia Disposables, Respiratory Devices, Respiratory Disposables and Others Summary GlobalData’s new report, "Mexico Anesthesia and Respiratory Devices Market Outlook to 2021 - Airway and Anesthesia Devices, Anesthesia Machines, Pain Managemen …
- 家庭用AVケーブルの世界市場：HDMI、RCA、DVI、VGAThe global AV cables for residential market size was valued at $273.0 million in 2018, and is projected to reach $502.1 million by 2026, growing at a CAGR of 7.7% from 2019 to 2026. AV cables are the connecting components, which are used in multimedia devices for communication of audio and video signals. The cables either provide electrical, optical, or digital modes of transfer. Most of these cab …
- 世界の無人航空機ペイロード（UAV Payload）市場動向2013-2023：地域別分析"The Global UAV Payload Market 2012-2022 - Country Analysis: Market Profile" provides details of the key markets in each region, offering an analysis of the top segments of UAV Payload, expected to be in demand. It also investigates the top three expected UAV Payload programs, in terms of demand in the key markets in each region.
- 脊椎手術機器の世界市場2018-2022About Spinal Surgery Devices Spine surgery helps to restore functions of the spine by treating spinal disorders such as spine deformities, disc herniation, spondylolisthesis, scoliosis, degenerative discs, trauma, spinal stenosis, and tumors in the spine region. Technavio’s analysts forecast the global spinal surgery devices market will post a revenue close to USD 13 billion by 2022. Covered in th …
- スペインの血液バンク市場2014This report provides an overview of the Spanish blood banking market, including sales and market shares of leading suppliers of blood typing, grouping and infectious disease screening/NAT tests, as well as test volume and sales forecasts by market segment.Table of ContentsBusiness Environment Market StructureMarket Size, Growth and Major Suppliers’ Sales and Market Shares & …
- 世界の貴金属産業分析（ファイブフォース分析）：Global Precious Metals Industry: Porter’s Five Forces AnalysisSilver, gold, platinum, palladium, diamonds and rhodium constitute the precious metals sector. After witnessing a period of fluctuation in growth during the years 2008-2012, the global precious metals industry is back on track to post substantially strong growth rates in the coming years. Aruvian Research analyzes the Global Precious Metals Industry in Michael Porter’s Five Forces Analysis. It use …
- 自律データプラットフォームの世界市場予測（～2024年）The global autonomous data platform market size is expected to grow from USD 810 million in 2019 to USD 2,210 million by 2024, at a CAGR of 22.2% during the forecast period The rise in adoption of cognitive computing technology and advanced analytics, increasing volume of unstructured data (due to the phenomenal growth of interconnected devices and social media), and increasing volume of complex d …
- WiFiインフラ市場分析（The Definitive Analysis of WiFi Infrastructure and Market Update）Wireless broadband services are critical to the next wave of development in information technology. Wire-less networks and provide mobility and ease of installation, a factor which is significant in the rapid uptake of mobile telephone technology across the developing world where fixed network infrastructure would be prohibitively expensive to install. How will WiFi hold up against WiMAX? What ven …
- 心臓補装具の世界市場：心臓人工弁、冠動脈ステントAbout cardiac prosthetic devices Prosthetic devices are used to replace or support the function of a missing or infirm part in the body. Cardiac prosthetic devices such as stents and prosthetic heart valves are used to maintain the proper functionality of the heart. Stents are used to maintain the blood flow, which reduces due to blockage in the arteries, whereas prosthetic heart valves are being …
- ロボット掃除機の世界市場2016-2020About Robotic Vacuum Cleaner A robotic vacuum cleaner (robovac) is a self-sufficient machine equipped with a vacuum cleaning system and an intelligent software program that runs the machine. Robovacs are used to clean living spaces, pools, and gutters - thus easing house chores for the user. Advanced versions of robotic vacuum cleaners comprise lasers or infrared sensors that ensure intelligent an …
- 世界の整形外科外傷治療装置市場動向（2012-2016）TechNavio's analysts forecast the Global Orthopedic Trauma Devices market to grow at a CAGR of 6.44 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Orthopedic Trauma Devices market has also been witnessing the increasing use of locking and hybrid plates. However, the lack of reimbursement benefits could pos …
- 不応性慢性リンパ性白血病：グローバル臨床試験レビュー（2014年上半期）Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Refractory Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2014" provides data on the Refractory Chronic Lymphocytic Leukemia (CLL) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ref …
- ヒューマンセントリックライティング（HCL）の世界市場2019-2023Global Human-centric Lighting Market: About this market Human-centric lighting also termed as tunable white lighting or circadian lighting, enables the user to adjust the color temperature and alter the intensity of the light on a real-time basis. Technavio’s human-centric lighting market analysis considers sales from both residential and commercial end-users. Our analysis also considers the sales …
- コンクリート補強繊維の世界市場About Concrete Fibers Concrete fibers are fibrous materials that are added to concrete to increase its structural integrity. These are tiny thread-like structures that are used in concrete to improve its strength and properties. Technavio’s analysts forecast the global concrete fibers market to grow at a CAGR of 7.28% during the period 2017-2021. [Covered in this report] The report covers the pres …
